Company Filing History:
Years Active: 2015-2020
Title: Marco Brusasca: Innovator in Pharmaceutical Chemistry
Introduction
Marco Brusasca is a notable inventor based in Valenza, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation and purification of important compounds. With a total of two patents to his name, Brusasca's work has implications for both antiviral and antitumor agents.
Latest Patents
Brusasca's latest patents include a process for the preparation of allopregnanolone and a method for the synthesis of nucleosides. The first patent details a method for purifying allopregnanolone, which involves dissolving the compound in acetonitrile and crystallizing it to remove impurities. The second patent describes a process for preparing nucleosides and their derivatives through a coupling reaction, which is particularly useful for creating antiviral and antitumor agents. This process ensures a residual tin content lower than 300 ppm, enhancing the safety and efficacy of the resulting compounds.
Career Highlights
Throughout his career, Brusasca has worked with notable companies such as Farmabios S.p.a. and Farmabios S.p.s. His experience in these organizations has allowed him to develop and refine his innovative techniques in pharmaceutical chemistry.
Collaborations
Brusasca has collaborated with esteemed colleagues, including Enrico Torregrossa and Cristina Manfrotto. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Marco Brusasca is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the preparation and purification of vital compounds. His contributions continue to impact the fields of medicine and drug development.